Fuente: Fortune
Daraxonrasib nearly doubled pancreatic cancer survival to 13.2 months — but the IRA's "Pill Penalty" threatens the system that produced it.
Leer en la Fuente
Noticias Relacionadas
Lista de Noticias
When 10,000 doctors stood up and cheered for a cancer drug — America’s innovation machine made it possible
America
Fortune
Hace 10h
